Skip to main content

Table 1 Clinicopathological characteristic and univariate analysis of prognostic factors in the 38 study patients

From: Decision-making in postoperative chemotherapy for ovarian metastasis from colorectal cancer: a retrospective single-center study

 

No. of patients (%)

MST (months)

P-value

Age

  

0.484

 <49 years

16 (42.1)

23.7

 

 >50 years

22 (57.9)

27.2

 

Menstrual status

  

0.061

 Pre-menopausal

10 (26.3)

57.4

 

 Post-menopausal

28 (73.7)

26.6

 

Symptoms

  

0.845

 Yes

19 (50.0)

27.2

 

 No

19 (50.0)

26.2

 

Location

  

0.247

 Proximal colon

12 (31.6)

21.1

 

 Distal colon

19 (50.0)

28.4

 

 Rectum

7 (18.4)

27.7

 

Differentiation

  

0.962

 Well or moderate

31 (81.6)

27.2

 

 Poor or mucinous

4 (10.5)

18.1

 

Depth of invasion

  

0.377

 T2–3

12 (31.6)

47.8

 

 T4

24 (63.2)

27.2

 

Lymph node metastasis

  

0.358

 Positive

29 (76.3)

26.6

 

 Negative

9 (23.7)

28.9

 

Timing of metastasis

  

0.775

 Synchronous

9 (23.7)

27.8

 

 Metachronous

29 (76.3)

27.2

 

Tumor size

  

0.663

 <12.0 cm

15 (39.5)

28.9

 

 >12.1 cm

23 (60.5)

26.6

 

Side of metastasis

  

0.125

 Unilateral

24 (63.2)

28.4

 

 Bilateral

14 (36.8)

23.7

 

Peritoneal dissemination

  

0.040

 Yes

23 (60.5)

26.6

 

 No

15 (39.5)

57.4

 

Combined metastasis

  

0.0005

 Ovarian metastasis only

7 (18.4)

Not reached

 

 Other metastases

31 (81.6)

26.2

 

Operation time

  

0.019

 <169 min

25 (65.8)

28.9

 

 >170 min

13 (34.2)

16.5

 

Complete resection

  

0.0004

 R0

8 (21.1)

Not reached

 

 R1/2

30 (78.9)

26.2

 
  1. MST median survival time